Published in Rev Infect Dis on February 06, 1987
Pathogenesis of human immunodeficiency virus infection. Microbiol Rev (1993) 5.88
Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med (2006) 4.97
Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency. J Virol (1993) 1.85
Clinical course of primary HIV infection: consequences for subsequent course of infection. BMJ (1989) 1.60
Apoptotic regulation of T cells and absence of immune deficiency in virus-infected gamma interferon receptor knockout mice. J Virol (1998) 1.32
Pathogenesis and host response in Syrian hamsters following intranasal infection with Andes virus. PLoS Pathog (2011) 1.17
Bystander sensitization to activation-induced cell death as a mechanism of virus-induced immune suppression. J Virol (2000) 1.13
Trained immunity or tolerance: opposing functional programs induced in human monocytes after engagement of various pattern recognition receptors. Clin Vaccine Immunol (2014) 1.11
Densitometric analysis of Western blot (immunoblot) assays for human immunodeficiency virus antibodies and correlation with clinical status. J Clin Microbiol (1987) 1.07
Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression. Clin Exp Immunol (1992) 1.01
Fatal Staphylococcal infection following classic Dengue fever. Am J Trop Med Hyg (2010) 0.98
Immunosuppression during acute infection with foot-and-mouth disease virus in swine is mediated by IL-10. PLoS One (2009) 0.98
Lymphocytic choriomeningitis virus-induced immunodepression: inherent defect of B and T lymphocytes. J Virol (1990) 0.97
Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation. Transplantation (1994) 0.91
The biology of FoxP3: a key player in immune suppression during infections, autoimmune diseases and cancer. Adv Exp Med Biol (2009) 0.85
Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections. Clin Exp Immunol (1989) 0.85
Effect of high dose vitamin C on Epstein-Barr viral infection. Med Sci Monit (2014) 0.85
Out-of-sequence signal 3 as a mechanism for virus-induced immune suppression of CD8 T cell responses. PLoS Pathog (2014) 0.84
Evidence for prostaglandin-producing suppressor cells in drug-induced liver injury and implications in the diagnosis of drug sensitization. Clin Exp Immunol (1992) 0.83
Cellular immunology of HIV-infection. Clin Exp Immunol (1988) 0.83
Are we causing the recurrence-impact of perioperative period on long-term cancer prognosis: Review of current evidence and practice. J Anaesthesiol Clin Pharmacol (2014) 0.83
Sequential serological studies of homosexual men with and without HIV infection. Epstein-Barr virus activation preceding and following HIV seroconversion. Clin Exp Immunol (1991) 0.82
The role of CD4+ lymphocytes in the activation of non-specific suppressor cells by antigen. Immunology (1989) 0.79
Cavity Forming Pneumonia Due to Staphylococcus aureus Following Dengue Fever. Am J Trop Med Hyg (2015) 0.78
Monocyte disorder causing cellular immunodeficiency: a family study. Clin Exp Immunol (1990) 0.77
Impaired responsiveness to gamma interferon of macrophages infected with lymphocytic choriomeningitis virus clone 13: susceptibility to histoplasmosis. Infect Immun (1995) 0.77
Study of immune function in inbred miniature pigs vaccinated and challenged with suid herpesvirus 1. Can J Vet Res (1995) 0.76
Suppression of lymphocyte proliferation by parainfluenza virus type 3-infected bovine alveolar macrophages. Immunology (1993) 0.75
Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes. J Cell Biol (1988) 4.63
A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature (1988) 4.09
Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J Immunol (1995) 3.69
On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J Immunol (1997) 2.14
An investigation of uterine nitric oxide production in mares susceptible and resistant to persistent breeding-induced endometritis and the effects of immunomodulation. Reprod Domest Anim (2012) 1.98
Defense mechanisms against bovine herpesvirus: relationship of virus-host cell events to susceptibility to antibody-complement cell lysis. Infect Immun (1975) 1.98
Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J Immunol (1995) 1.94
Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J Immunol (1992) 1.92
Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes. Infect Immun (1980) 1.85
CD4+CD8- T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J Immunol (1994) 1.83
Host responses to infectious bovine rhinotracheitis virus. III. Isolation and immunologic activities of bovine T lymphocytes. J Immunol (1974) 1.79
Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology. J Virol (1989) 1.72
Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice. J Immunol (1995) 1.72
Disease in the scurfy (sf) mouse is associated with overexpression of cytokine genes. Eur J Immunol (1996) 1.71
Cell-mediated immunity to herpes simplex virus: specificity of cytotoxic T cells. Infect Immun (1980) 1.71
Host defense mechanisms against infectious bovine rhinotracheitis virus: in vitro stimulation of sensitized lymphocytes by virus antigen. Infect Immun (1974) 1.69
Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J Virol (2001) 1.64
The role of T cell immunity in control of herpes simplex virus. Curr Top Microbiol Immunol (1992) 1.63
Endogenous regulation of macrophage proliferative expansion by colony-stimulating factor-induced interferon. Science (1984) 1.61
Transplantation of T cell-mediated, lymphoreticular disease from the scurfy (sf) mouse. Am J Pathol (1994) 1.59
Antibody-dependent cell-mediated cytotoxicity in cows: comparison of effector cell activity against heterologous erthrocyte and herpesvirus-infected bovine target cells. Infect Immun (1976) 1.59
Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis. Invest Ophthalmol Vis Sci (1984) 1.58
A new influenza A virus infection in turkeys II. A highly pathogenic variant, a/turkey/ontario 772/66. Can Vet J (1968) 1.54
Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes. Infect Immun (1983) 1.43
Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J Virol (1997) 1.42
Immunopathogenesis of herpetic ocular disease. Immunol Res (1997) 1.40
Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize virus nonstructural proteins. J Virol (1988) 1.37
Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cells. J Virol (1987) 1.36
Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro. J Exp Med (1992) 1.36
Host defense mechanisms against infectious bovine rhinotracheitis virus. II. Inhibition of viral plaque formation by immune peripheral blood lymphocytes. Cell Immunol (1975) 1.35
Mechanisms of resistant of herpesviruses: comparison of the effectiveness of different cell types in mediating antibody-dependent cell-mediated cytotoxicity. Infect Immun (1977) 1.34
Mechanisms of recovery from Herpesvirus infections -a review. Can J Comp Med (1978) 1.34
Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. J Virol (1992) 1.32
Phenotypic and functional studies on ocular T cells during herpetic infections of the eye. J Immunol (1992) 1.32
Equine herpesvirus-1 consensus statement. J Vet Intern Med (2009) 1.31
Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes. Invest Ophthalmol Vis Sci (1992) 1.30
Role of mucosal immunity in herpes simplex virus infection. J Immunol (1998) 1.29
Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses. Infect Immun (1976) 1.29
Role of T-lymphocyte subsets in recovery from herpes simplex virus infection. J Virol (1984) 1.29
The role of antibody dependent cytotoxicity in recovery from herpesvirus infections. Cell Immunol (1976) 1.27
Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse-models. J Virol (1995) 1.27
Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J Leukoc Biol (1997) 1.25
Vaccination with recombinant vaccinia viruses expressing ICP27 induces protective immunity against herpes simplex virus through CD4+ Th1+ T cells. J Virol (1995) 1.25
The direct antiviral cytotoxicity by bovine lymphocytes is not restricted by genetic incompatibility of lymphocytes and target cells. J Immunol (1977) 1.24
Cell-mediated immunity to herpes simplex virus: recognition of type-specific and type-common surface antigens by cytotoxic T cell populations. Infect Immun (1981) 1.24
Control of stromal keratitis by inhibition of neovascularization. Am J Pathol (2001) 1.24
A new influenza virus infection in turkeys. I. Isolation and characterization of virus 6213. Can Vet J (1968) 1.22
In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes. J Immunol (1992) 1.22
Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10. J Immunol (1997) 1.21
Comparison of the antiviral effects of 5-methoxymethyl-deoxyuridine with 5-iododeoxyuridine, cytosine arabinoside, and adenine arabinoside. Antimicrob Agents Chemother (1975) 1.21
Herpetic stromal keratitis in the reconstituted scid mouse model. J Virol (1993) 1.21
Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses. J Exp Med (1982) 1.20
Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies. J Infect Dis (1991) 1.18
The role of neutrophils in antiviral defense--in vitro studies on the mechanism of antiviral inhibition. J Immunol (1977) 1.18
Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J Virol (1996) 1.17
Antibody dependent cytotoxicity mediated by neutrophils: a possible mechanism of antiviral defense. J Reticuloendothel Soc (1976) 1.17
Role of interferon-gamma in immunity to herpes simplex virus. J Leukoc Biol (1996) 1.16
Immunopathology of herpes simplex virus infections. Curr Top Microbiol Immunol (1992) 1.16
Virus-induced immunoinflammatory lesions in the absence of viral antigen recognition. J Immunol (1998) 1.16
Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses. Int Immunol (1995) 1.16
The mammary gland of the ox: a convenient source for the repeated collection of neutrophils and macrophages. J Reticuloendothel Soc (1976) 1.15
Augmentation of immunity to herpes simplex virus by in vivo administration of interleukin 2. J Immunol (1985) 1.14
Neutrophils in antiviral immunity: inhibition of virus replication by a mediator produced by bovine neutrophils. J Infect Dis (1980) 1.14
Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules. J Immunol (2001) 1.14
Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice. Infect Immun (1995) 1.13
Bystander activation involving T lymphocytes in herpetic stromal keratitis. J Immunol (2001) 1.13
The mouse model and understanding immunity to herpes simplex virus. Rev Infect Dis (1992) 1.12
Defense mechanisms against infectious bovine rhinotracheitis virus: inhibition of virus infection by murine macrophages. Infect Immun (1975) 1.10
Murine cytotoxic T lymphocytes specific for herpes simplex virus type 1 recognize the immediate early protein ICP4 but not ICP0. J Gen Virol (1990) 1.10
Proportion of T and B lymphocytes in lesions of Marek's disease: theoretical implications for pathogenesis. J Immunol (1973) 1.10
Foals are interferon gamma-deficient at birth. Vet Immunol Immunopathol (2006) 1.09
DNA vaccines -- a modern gimmick or a boon to vaccinology? Crit Rev Immunol (1997) 1.09
Anti-theta serum-induced supression of the cellular transfer of tumour-specific immunity to a syngeneic plasma cell tumour. Nat New Biol (1972) 1.08
HSV-1-mediated modulation of cytokine gene expression in a permissive cell line: selective upregulation of IL-6 gene expression. Virology (1996) 1.08
Bystander activation of CD4(+) T cells can represent an exclusive means of immunopathology in a virus infection. Eur J Immunol (1999) 1.08
Application of the intracellular gamma interferon assay to recalculate the potency of CD8(+) T-cell responses to herpes simplex virus. J Virol (2000) 1.08
The role of the thymus in maturational development of phytohemagglutinin and pokeweed mitogen responsiveness. Cell Immunol (1973) 1.07
Frequency of herpes simplex virus-specific cytotoxic T lymphocyte precursors in lymph node cells of infected mice. Immunology (1984) 1.07
Production of key molecules by ocular neutrophils early after herpetic infection of the cornea. Exp Eye Res (1998) 1.07
A method for the collection of nasal secretions from the horse and cow. Res Vet Sci (1970) 1.07
Herpesviruses--immune escape artists? Clin Infect Dis (1992) 1.07
pH sensitive liposomes provide an efficient means of sensitizing target cells to class I restricted CTL recognition of a soluble protein. J Immunol Methods (1991) 1.07
Herpes simplex virus latency and the immune response. Curr Opin Microbiol (1998) 1.06
A new influenza A virus infection in turkeys. IV. Experimental susceptibility of domestic birds to virus strain turkey-Ontario 7732-1966. Arch Gesamte Virusforsch (1969) 1.06
Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: implications in herpetic stromal keratitis. J Interferon Cytokine Res (1998) 1.06
Induction of cytotoxic T lymphocytes in vivo with protein antigen entrapped in membranous vehicles. J Immunol (1992) 1.06
Solid-phase radioimmunoassay for detecting bovine (neonatal calf diarrhea) rotavirus antibody. J Clin Microbiol (1977) 1.06
Recognition by and in vitro induction of cytotoxic T lymphocytes against predicted epitopes of the immediate-early protein ICP27 of herpes simplex virus. J Virol (1993) 1.05
Immune control of herpesvirus latency. Can J Microbiol (1979) 1.05
The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: clearance of local infection. J Immunol (1987) 1.05
The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity. J Immunol (1972) 1.05
Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts. Int J Cancer (1997) 1.04
Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize immediate-early protein ICP27. J Virol (1991) 1.04
Characterization of surface receptors on bovine leukocytes. Int Arch Allergy Appl Immunol (1978) 1.04
Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse. J Anim Sci (2007) 1.03
Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines. J Virol (2001) 1.03
Induction of cytotoxic T lymphocytes against herpes simplex virus type i: role of accessory cells and amplifying factor. J Immunol (1980) 1.02